Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
This is an observational study that does not change routine care.

 The primary objective of this study is to investigate the role of
 antibiogramme-antibiofilmogramme concordance (in terms of S. aureus strains and prescribed
 antibiotics) in the presence/absence of S. aureus strains at the end of a first regimen of
 antibiotics.
The secondary objectives are:

 A. Should a first regimen of antibiotics fail, to describe the bacterial community present in
 the wound, and its potential to create biofilms.

 B. To investigate the role of antibiogramme-antibiofilmogramme concordance (in terms of S.
 aureus strains and prescribed antibiotics) in wound healing.

 C. To study the potential role of additional antibiofilmogramme data, as well as that of
 other pre-defined co-factors, in predicting wound changes.

 D. Create an S. aureus strain collection for future ancillary studies.
Inclusion Criteria:

 -  The patient must have given his/her informed and signed consent

 -  The patient must be insured or beneficiary of a health insurance plan

 -  The patient is available for 7 to 10 weeks of follow-up

 -  Patient with a foot wound (at least stage 2 or more) that is infected by at least 1
 strain of S. aureus

 Exclusion Criteria:

 -  The patient is participating in, or has participated in within the past 3 months,
 another interventional study, or is currently in an exclusion period determined by a
 preceding study

 -  The patient is under judicial protection, under tutorship or curatorship

 -  The patient refuses to sign the consent

 -  It is impossible to correctly inform the patient

 -  The patient is pregnant, parturient, or breastfeeding

 -  Emergency situation precluding correct study implementation